Bozic Carmen sold VRTX
June 26, 2026 · Form 4 insider transaction
Bozic Carmen sold 596 shares of Vertex Pharmaceuticals Incorporated at $482.50 per share, a transaction worth $287.6K. The trade was recorded as open-market sale under a pre-scheduled Rule 10b5-1 plan and disclosed on an SEC Form 4, filed 4 days after the transaction.
Direction
Disposed (sell-side)
Shares
596
Price
$482.50
Total value
$287.6K
InsiderBozic Carmen
Role—
SecurityCommon Stock
Transaction codeS: Open-market sale
Transaction dateJune 26, 2026
Filing dateJune 30, 2026
Shares owned after15,337
OwnershipDirect
10b5-1 planYes
AmendedNo
Footnotes
Transaction made pursuant to Dr. Bozic's company approved trading plan under Rule 10b5-1, which was entered into on 11/20/2025.